Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Ischemic Heart Disease

  Free Subscription


1 Am Heart J
6 Am J Cardiol
6 Angiology
2 Ann Intern Med
1 Ann Thorac Surg
1 Arterioscler Thromb Vasc Biol
3 Cardiovasc Res
3 Circ Cardiovasc Imaging
6 Circ Cardiovasc Interv
4 Circ J
1 Circ Res
9 Circulation
4 Clin Cardiol
2 Hypertension
8 Int J Cardiol
4 J Am Coll Cardiol
3 J Clin Endocrinol Metab
1 J Mol Cell Cardiol
1 J Thorac Cardiovasc Surg
1 Mol Cell Biochem
4 N Engl J Med

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. DESAI RJ, Glynn RJ, Everett BM, Schneeweiss S, et al
    Comparative effectiveness of empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.
    Am Heart J. 2022 Sep 20. pii: S0002-8703(22)00193.
    PubMed         Abstract available

    Am J Cardiol

  2. OMAR A, Senguttuvan NB, Ueyama H, Kuno T, et al
    Meta-Analysis Comparing Fractional Flow Reserve and Angiography-Guided Complete Revascularization of Nonculprit Artery for ST-Elevation Myocardial Infarction.
    Am J Cardiol. 2022 Sep 14. pii: S0002-9149(22)00835.
    PubMed         Abstract available

  3. MOLEDINA SM, Mannan F, Weight N, Alisiddiq Z, et al
    Impact of QRS Duration on Non-ST-Segment Elevation Myocardial Infarction (from a National Registry).
    Am J Cardiol. 2022 Sep 11. pii: S0002-9149(22)00856.
    PubMed         Abstract available

  4. THOMAS AS, Falk EE, Mahoney S, Knight JH, et al
    Long-Term Outcomes of Cardiovascular Operations in Children With Connective Tissue Disorders.
    Am J Cardiol. 2022 Sep 19. pii: S0002-9149(22)00417.
    PubMed         Abstract available

  5. AL-ABDOUH A, Mhanna M, Jabri A, Abusnina W, et al
    Meta-Analysis of Coronary Computed Tomography Versus Invasive Coronary Angiography in Stable Chest Pain.
    Am J Cardiol. 2022 Sep 17. pii: S0002-9149(22)00855.

  6. KUBO K, Okamura T, Sugiyama D, Hisamatsu T, et al
    Effect of Chronic Kidney Disease or Anemia or Both on Cardiovascular Mortality in a 25-Year Follow-Up Study of Japanese General Population (From NIPPON DATA90).
    Am J Cardiol. 2022 Sep 17. pii: S0002-9149(22)00912.
    PubMed         Abstract available

  7. NATANZON SS, Fardman A, Mazin I, Barbash I, et al
    Usefulness of Coronary Artery Calcium Score to Rule Out Obstructive Coronary Artery Disease Before Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2022 Sep 14. pii: S0002-9149(22)00852.
    PubMed         Abstract available


  8. RODRIGUEZ-CORTES FJ, Jimenez-Hornero JE, Alcala-Diaz JF, Jimenez-Hornero FJ, et al
    Daylight Saving Time transitions and Cardiovascular Disease in Andalusia: Time Series Modeling and Analysis Using Visibility Graphs.
    Angiology. 2022 Sep 14:33197221124779. doi: 10.1177/00033197221124779.
    PubMed         Abstract available

  9. KARADENIZ FO, Sancaktepe EA, Karadeniz Y
    High Triglyceride-Glucose Index is Associated With Poor Prognosis in Patients With Acute Coronary Syndrome in Long-Term Follow-Up.
    Angiology. 2022 Sep 16:33197221124763. doi: 10.1177/00033197221124763.
    PubMed         Abstract available

  10. CELIK A, Esin FK, Emren SV, Kiris T, et al
    The Clinical Value of the Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy Score in Predicting Long-Term Major Adverse Cardiovascular And Cerebrovascular Events and Major Bleeding in
    Angiology. 2022 Sep 14:33197221127073. doi: 10.1177/00033197221127073.
    PubMed         Abstract available

  11. VASHEE C, Mares A, Lehker A, Mukherjee D, et al
    Optimal Treatment of Tapered Coronary Artery Lesions.
    Angiology. 2022 Sep 15:33197221127598. doi: 10.1177/00033197221127598.
    PubMed         Abstract available

  12. GAHLAN P, Gupta D, Mutha S, Shah S, et al
    Clinical Predictors of Coronary Artery Ectasia.
    Angiology. 2022 Sep 13:33197221126251. doi: 10.1177/00033197221126251.
    PubMed         Abstract available

  13. YASAR E, Bayramoglu A, Karakus Y, Cakmak T, et al
    The CHA2DS2-VASc Risk Score Predicts Total Occlusion in Infarct-Related Arteries in Patients With NSTEMI: Reply.
    Angiology. 2022;73:987.

    Ann Intern Med

  14. CHEW DS, Whitelaw S, Vaduganathan M, Mark DB, et al
    Patient-Reported Outcomes Measures in Cardiovascular Disease: An Evidence Map of the Psychometric Properties of Health Status Instruments.
    Ann Intern Med. 2022 Sep 20. doi: 10.7326/M22-2234.
    PubMed         Abstract available

  15. INOUE-CHOI M, Ramirez Y, Cornelis MC, Berrington de Gonzalez A, et al
    Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank : A Prospective Cohort Study.
    Ann Intern Med. 2022 Aug 30. doi: 10.7326/M22-0041.
    PubMed         Abstract available

    Ann Thorac Surg

  16. PIENTA MJ, Theurer P, He C, Clark M, et al
    Contemporary Management of Ischemic Mitral Regurgitation at Coronary Artery Bypass Grafting.
    Ann Thorac Surg. 2022 Sep 20. pii: S0003-4975(22)01224.
    PubMed         Abstract available

    Arterioscler Thromb Vasc Biol

  17. MCFADYEN JD, Gardiner EE
    An Aspirin a Day....
    Arterioscler Thromb Vasc Biol. 2022;42:1217-1219.


  18. YUN I
    Regional inequality in myocardial infarction treatment cannot be blamed on effectiveness of individual cardiologists.
    BMJ. 2022;378:o2235.

  19. XIE W, Wang Y, Xiao S, Qiu L, et al
    Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis.
    BMJ. 2022;378:e070244.
    PubMed         Abstract available

    Cardiovasc Res

  20. LECOUR S, Du Pre BC, Botker HE, Brundel BJJM, et al
    Circadian rhythms in ischaemic heart disease: key aspects for preclinical and translational research: position paper of the ESC working group on cellular biology of the heart.
    Cardiovasc Res. 2022;118:2566-2581.
    PubMed         Abstract available

  21. HUBERT F, Payan SM, Pelce E, Bouchard L, et al
    FGF10 promotes cardiac repair through a dual cellular mechanism increasing cardiomyocyte renewal and inhibiting fibrosis.
    Cardiovasc Res. 2022;118:2625-2637.
    PubMed         Abstract available

  22. NAH J, Shirakabe A, Mukai R, Zhai P, et al
    Ulk1-dependent alternative mitophagy plays a protective role during pressure overload in the heart.
    Cardiovasc Res. 2022;118:2638-2651.
    PubMed         Abstract available

    Circ Cardiovasc Imaging

  23. CAVUS E, Schneider JN, Bei der Kellen R, di Carluccio E, et al
    Impact of Sex and Cardiovascular Risk Factors on Myocardial T1, Extracellular Volume Fraction, and T2 at 3 Tesla: Results From the Population-Based, Hamburg City Health Study.
    Circ Cardiovasc Imaging. 2022;15:e014158.
    PubMed         Abstract available

  24. JEROSCH-HEROLD M, Petersen SE
    Cardiovascular Magnetic Resonance Tissue Characterization by T1 and T2 Mapping: A Moving Target in Need of Stable References.
    Circ Cardiovasc Imaging. 2022;15:e014743.

  25. SINGH A, Kwiecinski J, Miller RJH, Otaki Y, et al
    Deep Learning for Explainable Estimation of Mortality Risk From Myocardial Positron Emission Tomography Images.
    Circ Cardiovasc Imaging. 2022;15:e014526.
    PubMed         Abstract available

    Circ Cardiovasc Interv

  26. RODRIGUEZ-LEOR O, de la Torre Hernandez JM, Garcia Camarero T, Garcia Del Blanco B, et al
    Instantaneous Wave Free Ratio for the Assessment of Intermediate Left Main Coronary Artery Stenosis: Correlations with FFR/IVUS and Prognostic Implications: The iLITRO - EPIC07 Study.
    Circ Cardiovasc Interv. 2022 Sep 16. doi: 10.1161/CIRCINTERVENTIONS.122.012328.
    PubMed         Abstract available

  27. PIROTH Z, Otsuki H, Zimmermann FM, Ferenci T, et al
    Prognostic Value of Measuring Fractional Flow Reserve after Percutaneous Coronary Intervention in patients with Complex Coronary Artery Disease: Insights from the FAME 3 Trial.
    Circ Cardiovasc Interv. 2022 Sep 19. doi: 10.1161/CIRCINTERVENTIONS.122.012542.
    PubMed         Abstract available

  28. SCHELLER B, Mangner N, Abdul Kader MASK, Wan Ahmad WA, et al
    Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions.
    Circ Cardiovasc Interv. 2022;15:e012305.
    PubMed         Abstract available

  29. AHN JM, Nakayoshi T, Hashikata T, Kashiyama K, et al
    Impact of Serial Coronary Stenoses on Various Coronary Physiologic Indices.
    Circ Cardiovasc Interv. 2022;15:e012134.
    PubMed         Abstract available

  30. ROMAGNOLI E, Ramazzotti V, Burzotta F, Gatto L, et al
    Definition of Optimal Optical Coherence Tomography-Based Stent Expansion Criteria: In-Stent Minimum Lumen Area Versus Residual Stent Underexpansion.
    Circ Cardiovasc Interv. 2022;15:e011496.
    PubMed         Abstract available

  31. CHEN Z, Matsumura M, Mintz GS, Noguchi M, et al
    Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis.
    Circ Cardiovasc Interv. 2022;15:e011693.
    PubMed         Abstract available

    Circ J

  32. WATANABE M, Higuchi R, Nanasato M, Iguchi N, et al
    Thromboembolic Pulmonary Hypertension Induced Myocardial Ischemia in a Patient With Anomalous Right Coronary Artery.
    Circ J. 2022 Apr 29. doi: 10.1253/circj.CJ-22-0115.

  33. MATSUMOTO S, Nakanishi R, Ichibayashi R, Honda M, et al
    Heart Rate and Mortality After Resuscitation in Patients With Out-of-Hospital Cardiac Arrest- Insights From the SOS-KANTO Registry.
    Circ J. 2022;86:1562-1571.
    PubMed         Abstract available

  34. GOHBARA M, Iwahashi N, Okada K, Ogino Y, et al
    A Simple Risk Score to Differentiate Between Coronary Artery Obstruction and Coronary Artery Spasm of Patients With Acute Coronary Syndrome Without Persistent ST-Segment Elevation.
    Circ J. 2022;86:1509-1518.
    PubMed         Abstract available

  35. KAWANO K, Yufu K, Shimomura T, Sato H, et al
    Prehospital 12-Lead Electrocardiography System in Oita Assisted Transport of "True" Acute Coronary Syndrome Patients to Optimal Institutes.
    Circ J. 2022;86:1481-1487.
    PubMed         Abstract available

    Circ Res

  36. HE H, Mulhern RM, Oldham WM, Xiao W, et al
    L-2-Hydroxyglutarate Protects Against Cardiac Injury via Metabolic Remodeling.
    Circ Res. 2022;131:562-579.
    PubMed         Abstract available


  37. BRADLEY EA, Winchester D, Alfonso CE, Carpenter AJ, et al
    Physician Wellness in Academic Cardiovascular Medicine: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Sep 19:101161CIR0000000000001093.
    PubMed         Abstract available

  38. O'DONNELL CJ, Bradner JE
    Bridging the Gap to Translating Genome-Wide Discoveries Into Therapies to Prevent and Treat Atherosclerotic Cardiovascular Disease.
    Circulation. 2022;146:930-933.

  39. REDDY VY, Petru J, Funasako M, Kopriva K, et al
    Coronary Arterial Spasm During Pulsed Field Ablation to Treat Atrial Fibrillation.
    Circulation. 2022 Sep 22:101161CIRCULATIONAHA122061497.
    PubMed         Abstract available

  40. LOWRY MTH, Doudesis D, Wereski R, Kimenai DM, et al
    Influence of Age on the Diagnosis of Myocardial Infarction.
    Circulation. 2022 Sep 15:101161CIRCULATIONAHA122059994.
    PubMed         Abstract available

  41. SONG R, Zhang L
    Response by Song and Zhang to Letters Regarding Article, "MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction".
    Circulation. 2022;146:e171-e172.

  42. DE D, Fu F, Ding M
    Letter by De et al Regarding Article, "MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction".
    Circulation. 2022;146:e170.

  43. HOU L, Xie M, Zhao G
    Letter by Hou et al Regarding Article, "MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction".
    Circulation. 2022;146:e169.

  44. ZHANG Q, Burrage MK, Shanmuganathan M, Gonzales RA, et al
    Artificial Intelligence for Contrast-free MRI: Scar Assessment in Myocardial Infarction Using Deep Learning-based Virtual Native Enhancement (VNE).
    Circulation. 2022 Sep 20. doi: 10.1161/CIRCULATIONAHA.122.060137.
    PubMed         Abstract available

  45. AHN JM, Kang DY, Yun SC, Hur SH, et al
    Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-up Outcomes of Multicenter Randomized Controlled BEST Trial.
    Circulation. 2022 Sep 19. doi: 10.1161/CIRCULATIONAHA.122.062188.
    PubMed         Abstract available

    Clin Cardiol

  46. CHEN C, Li X, Su Y, You Z, et al
    Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: "Real-world" evidence.
    Clin Cardiol. 2022 Sep 18. doi: 10.1002/clc.23898.
    PubMed         Abstract available

  47. NAZER RI, Albarrati AM
    The brain-before-heart strategy for coronary artery bypass grafting in the severely atherosclerotic aorta: A single-institution experience.
    Clin Cardiol. 2022 Sep 19. doi: 10.1002/clc.23913.
    PubMed         Abstract available

  48. SHAIK A, Kosiborod M, de Lemos JA, Gao Q, et al
    Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD).
    Clin Cardiol. 2022 Sep 19. doi: 10.1002/clc.23923.
    PubMed         Abstract available

  49. IVEY SL, Hanley HR, Taylor C, Stock E, et al
    Early identification and treatment of women's cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers.
    Clin Cardiol. 2022 Sep 20. doi: 10.1002/clc.23921.
    PubMed         Abstract available


  50. GYSELAERS W, Dreesen P, Staelens AS, Tomsin K, et al
    First-Trimester Normotension Is a Weak Indicator of Normal Maternal Cardiovascular Function.
    Hypertension. 2022 Sep 23:HYPERTENSIONAHA12219346.
    PubMed         Abstract available

  51. BIGALKE JA, Shan Z, Carter JR
    Orexin, Sleep, Sympathetic Neural Activity, and Cardiovascular Function.
    Hypertension. 2022 Sep 23:101161HYPERTENSIONAHA12219796.
    PubMed         Abstract available

    Int J Cardiol

  52. ZUERCHER MD, Harvey DJ, Au LE, Shadyab AH, et al
    Genetic admixture and cardiovascular disease risk in postmenopausal Hispanic women.
    Int J Cardiol. 2022;367:99-104.
    PubMed         Abstract available

  53. SIMSEK B, Jaffer FA, Kostantinis S, Karacsonyi J, et al
    Preprocedural coronary computed tomography angiography in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Int J Cardiol. 2022;367:20-25.
    PubMed         Abstract available

  54. WANG J, Li Y, Zhang S
    N(6)-methyladenosine modification: A vital role of programmed cell death in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2022;367:11-19.
    PubMed         Abstract available

  55. HOLZKNECHT M, Lechner I, Reinstadler SJ
    The circadian clock in STEMI: A further contributor to the development of MVO?
    Int J Cardiol. 2022;367:115-116.

  56. GONZALEZ-DEL-HOYO M, Rodriguez-Leor O, Cid-Alvarez AB, de Prado AP, et al
    Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort.
    Int J Cardiol. 2022;367:90-98.
    PubMed         Abstract available

  57. JUNG C, Rezar R, Wischmann P, Masyuk M, et al
    The role of anemia on admission in acute coronary syndrome - An umbrella review of systematic reviews and meta-analyses.
    Int J Cardiol. 2022;367:1-10.
    PubMed         Abstract available

  58. LIN HC, Chou SH, Fan PC, Zhu Z, et al
    The association between Day-1 urine cadmium excretion and 30-day mortality in patients with acute myocardial infarction: A multi-institutional cohort study.
    Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01321.
    PubMed         Abstract available

  59. SOKHAL BS, Matetic A, Paul TK, Velagapudi P, et al
    Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors.
    Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01387.
    PubMed         Abstract available

    J Am Coll Cardiol

  60. WANG N, Harris K, Hamet P, Harrap S, et al
    Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes.
    J Am Coll Cardiol. 2022;80:1147-1155.
    PubMed         Abstract available

    Cumulative Blood Pressure Measurement for Cardiovascular Disease Prediction: Promise and Pitfalls.
    J Am Coll Cardiol. 2022;80:1156-1158.

  62. JIN Z, Xu B, Yang X, Jia R, et al
    Coronary Intervention Guided by Quantitative Flow Ratio vs Angiography in Patients With or Without Diabetes.
    J Am Coll Cardiol. 2022;80:1254-1264.
    PubMed         Abstract available

  63. SMITS PC, Frigoli E, Vranckx P, Ozaki Y, et al
    Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.
    J Am Coll Cardiol. 2022;80:1220-1237.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  64. Correction to: "Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes".
    J Clin Endocrinol Metab. 2022 Sep 14. pii: 6698734. doi: 10.1210.

  65. NESTEL P, Loh WJ, Ward NC, Watts GF, et al
    New Horizons: Revival of Lipoprotein (a) as a risk factor for cardiovascular disease.
    J Clin Endocrinol Metab. 2022 Sep 15. pii: 6701631. doi: 10.1210.
    PubMed         Abstract available

  66. WU VC, Peng KY, Hu YH, Chang CC, et al
    Circulating Plasma Concentrations of ACE2 in Primary Aldosteronism and Cardiovascular Outcomes.
    J Clin Endocrinol Metab. 2022 Sep 19. pii: 6705062. doi: 10.1210.
    PubMed         Abstract available

    J Mol Cell Cardiol

  67. HAPKE N, Heinrichs M, Ashour D, Vogel E, et al
    Identification of a novel cardiac epitope triggering T-cell responses in patients with myocardial infarction.
    J Mol Cell Cardiol. 2022 Sep 16. pii: S0022-2828(22)00520.
    PubMed         Abstract available

    J Thorac Cardiovasc Surg

  68. LAZAR HL
    Commentary: Risk stratification for patients undergoing surgical ventricular restoration for ischemic cardiomyopathy-it's more than just the preoperative ejection fraction.
    J Thorac Cardiovasc Surg. 2022;164:1102-1103.

    Mol Cell Biochem

  69. NONG Y, Guo Y, Ou Q, Gumpert A, et al
    PU.1 inhibition does not attenuate cardiac function deterioration or fibrosis in a murine model of myocardial infarction.
    Mol Cell Biochem. 2022 Sep 17. pii: 10.1007/s11010-022-04561.
    PubMed         Abstract available

    N Engl J Med

  70. NATHAN DM, Lachin JM, Bebu I, Burch HB, et al
    Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
    N Engl J Med. 2022;387:1075-1088.
    PubMed         Abstract available

  71. RYDEN L, Standl E
    After Metformin - Next Steps for Type 2 Diabetes with Low Cardiovascular Risk.
    N Engl J Med. 2022;387:1136-1138.

  72. FUKAMACHI D, Okumura Y
    Giant Coronary-Artery Aneurysm.
    N Engl J Med. 2022;387:e23.

  73. HONDA S, Kawasaki T
    Wellens' Syndrome.
    N Engl J Med. 2022;387:e25.

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.